Fingerprint
Dive into the research topics of 'Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically